UA92718U - Method for preventing postoperative wound complications in allohernioplasty of anterior abdominal wall - Google Patents
Method for preventing postoperative wound complications in allohernioplasty of anterior abdominal wallInfo
- Publication number
- UA92718U UA92718U UAU201404111U UAU201404111U UA92718U UA 92718 U UA92718 U UA 92718U UA U201404111 U UAU201404111 U UA U201404111U UA U201404111 U UAU201404111 U UA U201404111U UA 92718 U UA92718 U UA 92718U
- Authority
- UA
- Ukraine
- Prior art keywords
- allohernioplasty
- abdominal wall
- anterior abdominal
- postoperative wound
- preventing postoperative
- Prior art date
Links
- 206010061468 Postoperative wound complication Diseases 0.000 title abstract 2
- 210000003815 abdominal wall Anatomy 0.000 title abstract 2
- 229940079593 drug Drugs 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 abstract 2
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 abstract 1
- GZSOSUNBTXMUFQ-NJGQXECBSA-N 5,7,3'-Trihydroxy-4'-methoxyflavone 7-O-rutinoside Natural products O(C[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](Oc2cc(O)c3C(=O)C=C(c4cc(O)c(OC)cc4)Oc3c2)O1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](C)O1 GZSOSUNBTXMUFQ-NJGQXECBSA-N 0.000 abstract 1
- KWTQSFXGGICVPE-WCCKRBBISA-N Arginine hydrochloride Chemical compound Cl.OC(=O)[C@@H](N)CCCN=C(N)N KWTQSFXGGICVPE-WCCKRBBISA-N 0.000 abstract 1
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 abstract 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 abstract 1
- 230000000141 anti-hypoxic effect Effects 0.000 abstract 1
- 239000003963 antioxidant agent Substances 0.000 abstract 1
- 230000003078 antioxidant effect Effects 0.000 abstract 1
- 229940009098 aspartate Drugs 0.000 abstract 1
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 abstract 1
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 abstract 1
- 230000001120 cytoprotective effect Effects 0.000 abstract 1
- GZSOSUNBTXMUFQ-YFAPSIMESA-N diosmin Chemical compound C1=C(O)C(OC)=CC=C1C(OC1=C2)=CC(=O)C1=C(O)C=C2O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)O1 GZSOSUNBTXMUFQ-YFAPSIMESA-N 0.000 abstract 1
- 229960004352 diosmin Drugs 0.000 abstract 1
- IGBKNLGEMMEWKD-UHFFFAOYSA-N diosmin Natural products COc1ccc(cc1)C2=C(O)C(=O)c3c(O)cc(OC4OC(COC5OC(C)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 IGBKNLGEMMEWKD-UHFFFAOYSA-N 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 abstract 1
- 229940025878 hesperidin Drugs 0.000 abstract 1
- 230000000936 membranestabilizing effect Effects 0.000 abstract 1
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
A method for preventing postoperative wound complications in allohernioplasty of the anterior abdominal wall provides for the use of the drugs containing Diosmin and Hesperidin. Furthermore, the complex treatment comprises the use of Tivortin aspartate as the drug possessing antihypoxic, membrane-stabilizing, cytoprotective, antioxidant, and detoxifying activities.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201404111U UA92718U (en) | 2014-04-16 | 2014-04-16 | Method for preventing postoperative wound complications in allohernioplasty of anterior abdominal wall |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201404111U UA92718U (en) | 2014-04-16 | 2014-04-16 | Method for preventing postoperative wound complications in allohernioplasty of anterior abdominal wall |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA92718U true UA92718U (en) | 2014-08-26 |
Family
ID=52682113
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAU201404111U UA92718U (en) | 2014-04-16 | 2014-04-16 | Method for preventing postoperative wound complications in allohernioplasty of anterior abdominal wall |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA92718U (en) |
-
2014
- 2014-04-16 UA UAU201404111U patent/UA92718U/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA033266B1 (en) | Hydroxyester derivatives, process for their preparation and pharmaceutical compositions containing them | |
| TW201613887A (en) | Antiproliferative compounds and methods of use thereof | |
| MX2016016593A (en) | Novel aminoalkyl benzothiazepine derivative and use thereof. | |
| TW201613872A (en) | IRAK4 inhibiting agents | |
| MX2016009332A (en) | Ligand-cytotoxicity drug conjugate, preparation method therefor, and uses thereof. | |
| WO2015160975A3 (en) | Combination of a pi3k inhibitor with a bcl-2 inhibitor for use in the treatment of cancer | |
| MX2015010791A (en) | Methods of treating cancer and preventing drug resistance. | |
| PH12017502376A1 (en) | Oral solid formulation containing irinotecan and method of preparing the same | |
| MY202127A (en) | Pyridazine derivatives for use in the prevention or treatment of an ataxic disorder | |
| MX2020001875A (en) | Polymorphic form of tg02. | |
| PH12017501071B1 (en) | Dihydropyrimidin-2-one compounds and medical use thereof | |
| ZA202200511B (en) | Ring-fused thiazolino 2-pyridones, methods for preparation thereof and their use in the treatment and/or prevention of tuberculosis | |
| WO2016074641A8 (en) | Use of nadh or salt thereof in preparing drug or health care product for phenylketonuria treatment | |
| PH12016502233A1 (en) | (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine | |
| PH12016502236A1 (en) | (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine | |
| GB2611705B (en) | Methods for the non-toxic treatment for opioid drug withdrawal combining noribogaine and cannabinoids | |
| PL3362056T3 (en) | Aminothiolester compounds or pharmaceutically acceptable salts thereof, for use in the treatment of cancer | |
| EP3153178A4 (en) | Method for treating cancer patients using folr1 targeted drug and antifolate, and drug | |
| UA92718U (en) | Method for preventing postoperative wound complications in allohernioplasty of anterior abdominal wall | |
| NZ717880A (en) | Glucopyranosyl-substituted indole-urea derivatives and their use as sglt inhibitors | |
| UA99622U (en) | Method for preventing postoperative wound complications after allohernioplasty of anterior abdominal wall | |
| UA99436U (en) | Method for prevention of postoperative wound complications after anterior abdominal wall allohernioplasty | |
| HK40091512A (en) | Methods for the non-toxic treatment for opioid drug withdrawal combining noribogaine and cannabinoids | |
| HK40091512B (en) | Methods for the non-toxic treatment for opioid drug withdrawal combining noribogaine and cannabinoids | |
| UA105673U (en) | Method for preventing early postoperative complications of abdominal wall allohernioplasty |